Doc RandyMD's Articles in Diabetes

uPublish.info Free Original Articles Content Free Publishing

Featured Authors This Month: .

Show All\|Display Category\|Title\|Newest\|Oldest
Controversial evidence on value of pioglitazone (Actos) for type 2 diabetes Based only on studies provided by and conducted directly by the drug manufacturer, this review reports a significantly reduced incidence only of the composite outcome of death, myocardial infarction, and stroke with pioglitazone (Actos) therapy. None of the same outcomes were significantly reduced on an individual basis. An earlier review of pioglitazone therapy in type 2 diabetes by the Cochrane Collaboration of all available published and peer-reviewed clinical trials found no significant evidence of improved patient-oriented outcomes. Similar to the other thiazolidinedione, rosiglitazone (Avandia), pioglitazone also increases the risk of serious heart failure in type 2 diabetics.

Publish for Free

Sign Up For Free Learn More

Please Support
Our Sponsors

Authors and Writers

Submit Articles Submission Guidelines Link to Us Member Login U Publish Store

Publishers

Article RSS Feeds Link to Us Contact Us

More

Link to Us Privacy Policy Terms of Service Submission Guidelines Top Authors Popular Articles

Article Aids

We Recommend SubmitYourArticle iSnare Article Marketer Published.com Article Directories Word Count Utility

Search U Publish by:

© 2005-2008 uPublish.info All Rights Reserved.
Use of our service is protected by our Privacy Policy and Terms of Service
U Publish - Source for Free Articles - Free Reprint Articles - Free Article Publishing